Norges Bank Makes New Investment in USANA Health Sciences, Inc. (NYSE:USNA)

Norges Bank acquired a new stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 26,549 shares of the company’s stock, valued at approximately $953,000. Norges Bank owned approximately 0.14% of USANA Health Sciences as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in USNA. KLP Kapitalforvaltning AS bought a new stake in USANA Health Sciences in the fourth quarter worth $83,000. American Century Companies Inc. grew its stake in shares of USANA Health Sciences by 12.3% in the 4th quarter. American Century Companies Inc. now owns 233,797 shares of the company’s stock worth $8,391,000 after buying an additional 25,522 shares in the last quarter. Quantbot Technologies LP bought a new stake in shares of USANA Health Sciences in the 4th quarter worth about $132,000. Royce & Associates LP increased its holdings in shares of USANA Health Sciences by 17.4% in the 4th quarter. Royce & Associates LP now owns 38,914 shares of the company’s stock worth $1,397,000 after buying an additional 5,771 shares during the last quarter. Finally, Pzena Investment Management LLC raised its position in shares of USANA Health Sciences by 3.6% during the 4th quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company’s stock valued at $39,015,000 after buying an additional 37,466 shares in the last quarter. 54.25% of the stock is owned by institutional investors.

Insider Buying and Selling at USANA Health Sciences

In related news, CEO Jim Brown sold 5,000 shares of USANA Health Sciences stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the sale, the chief executive officer now owns 15,716 shares in the company, valued at $463,150.52. This trade represents a 24.14 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Joshua Foukas sold 5,732 shares of the business’s stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $32.54, for a total transaction of $186,519.28. The disclosure for this sale can be found here. Insiders have sold 15,920 shares of company stock valued at $500,285 in the last quarter. 0.33% of the stock is owned by insiders.

Analyst Ratings Changes

USNA has been the topic of several analyst reports. Sidoti cut USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Finally, DA Davidson decreased their price target on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a report on Thursday, February 27th.

USANA Health Sciences Trading Down 0.3 %

USNA stock opened at $24.67 on Friday. The stock has a market cap of $466.39 million, a PE ratio of 8.72, a P/E/G ratio of 0.93 and a beta of 1.00. USANA Health Sciences, Inc. has a 12 month low of $23.67 and a 12 month high of $49.78. The company has a 50-day moving average price of $29.16 and a 200 day moving average price of $34.02.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.15. The business had revenue of $213.61 million during the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. Sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.